LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Clinical trials for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for hard-to-treat blood cancers
Disease control CompletedThis study tested an oral drug called LOXO-305 in 87 Chinese adults with lymphoma or chronic lymphocytic leukemia who had already received standard treatments. The goal was to see how safe and effective the drug is. Participation could last up to four years. The study is now comp…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New antibody therapy targets Hard-to-Treat blood cancers
Disease control CompletedThis early-stage study tested an experimental drug called JNJ-75348780 in 147 people with relapsed or refractory B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia. The drug is a bispecific antibody designed to help the immune system attack cancer cells. The main goal wa…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Triple-Drug cocktail shows promise for Tough-to-Treat blood cancer
Disease control CompletedThis study tested a combination of three drugs—ibrutinib, fludarabine, and pembrolizumab—in 15 people with high-risk or relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if the combination could produce a complete resp…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Chemo-Free hope: new combo shows promise for leukemia patients
Disease control CompletedThis study tested a chemotherapy-free treatment for people with untreated chronic lymphocytic leukemia (CLL). Participants received two drugs (ibrutinib and obinutuzumab) for nine months. If their cancer was in deep remission, they continued ibrutinib alone; if not, they got addi…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated May 01, 2026 15:57 UTC